Resources

In a severe extracellular streptococcal infection, classical complement activation proceeds via the binding of IgG\text{IgG} pentamers or clusters to bacterial surface antigens. The serum concentrations of the initial classical components are: [C1q]=1.80×10−7  M[\text{C1q}] = 1.80 \times 10^{-7}\;\text{M}, [C4]=2.00×10−6  M[\text{C4}] = 2.00 \times 10^{-6}\;\text{M}, [C2]=1.30×10−7  M[\text{C2}] = 1.30 \times 10^{-7}\;\text{M}, and [C3]=7.50×10−6  M[\text{C3}] = 7.50 \times 10^{-6}\;\text{M}. (a) Identify the exact enzymatic multi-subunit complex that constitutes the classical pathway C3\text{C3} convertase, and determine which single complement component among C4\text{C4} and C2\text{C2} acts as the theoretical stoichiometric limiting factor in the initial assembly of this convertase. (b) Although this pathway operates with a stoichiometric bottleneck at the level of the convertase, explain how the cascade generates millions of terminal membrane attack complexes (MACs, C5b-9\text{C5b-9}) from a single initial C1q\text{C1q} binding event, referencing the asymptotic catalytic amplification that occurs at the C3\text{C3} cleavage step.

Answer and steps

Final answer

(a) The classical C3\text{C3} convertase is C4b2a\text{C4b2a} (or C4b2b\text{C4b2b} under older nomenclature; explicitly formed by C4b\text{C4b} and C2a\text{C2a}). Since C2\text{C2} is present at 1.30×10−7  M1.30 \times 10^{-7}\;\text{M} compared to C4\text{C4} at 2.00×10−6  M2.00 \times 10^{-6}\;\text{M}, C2\text{C2} is the stoichiometric limiting component (1:11:1 stoichiometry); (b) Enzymatic amplification: a single fully assembled C4b2a\text{C4b2a} complex is a stable serine protease that does not act stoichiometrically, but catalytically hydrolyzes thousands of soluble native C3\text{C3} molecules into C3a\text{C3a} and C3b\text{C3b}. Each newly generated C3b\text{C3b} can covalently attach to the target membrane and recruit either Factor B\text{Factor B} (driving exponential alternative loop amplification) or associate with C4b2a\text{C4b2a} to form C5\text{C5} convertase (C4b2a3b\text{C4b2a3b}), which catalytically cleaves hundreds of C5\text{C5} molecules, thereby creating an asymptotic cascade amplification.

Steps

Part (a): Identification of the C3\text{C3} Convertase and Stoichiometric Limiting Factor

  1. Assembly of the Classical C3\text{C3} Convertase:

    • When the C1\text{C1} complex (C1q\text{C1q}, C1r\text{C1r}, C1s\text{C1s}) is activated by antibody clusters on the pathogen surface, the active serine protease C1s\text{C1s} cleaves native C4\text{C4} into C4a\text{C4a} and C4b\text{C4b}.
    • The reactive thioester in C4b\text{C4b} covalently binds to the microbial membrane.
    • Membrane-bound C4b\text{C4b} subsequently binds native C2\text{C2}, which is then cleaved by C1s\text{C1s} into C2b\text{C2b} and C2a\text{C2a}.
    • The catalytic fragment C2a\text{C2a} remains non-covalently associated with C4b\text{C4b}, forming the active enzymatic complex: Classical C3 Convertase=CX4bX2a\text{Classical C3 Convertase} = \ce{C4b2a} (Note: In older literature, this complex is sometimes denoted as CX4bX2b\ce{C4b2b}, but standard modern nomenclature designates the larger catalytic fragment as CX2a\ce{C2a}.)
  2. Determination of the Limiting Reactant:

    • The formation of CX4bX2a\ce{C4b2a} requires C4\text{C4} and C2\text{C2} in a strict 1:11:1 stoichiometric ratio: CX4b+CX2a⟶CX4bX2a\ce{C4b} + \ce{C2a} \longrightarrow \ce{C4b2a}
    • Comparing the given serum concentrations: [C4]=2.00×10−6  M[\text{C4}] = 2.00 \times 10^{-6}\;\text{M} [C2]=1.30×10−7  M[\text{C2}] = 1.30 \times 10^{-7}\;\text{M}
    • Because [C2]<[C4][\text{C2}] < [\text{C4}] by more than an order of magnitude (1.30×10−7  M≪2.00×10−6  M1.30 \times 10^{-7}\;\text{M} \ll 2.00 \times 10^{-6}\;\text{M}), C2\text{C2} serves as the theoretical stoichiometric bottleneck limiting the total number of CX4bX2a\ce{C4b2a} complexes that can assemble.

Part (b): Mechanism of Downstream Amplification

Although convertase assembly is constrained by the low physiological concentration of C2\text{C2}, the complement cascade circumvents this bottleneck through catalytic enzymatic turnover:

  1. Enzymatic (Non-Stoichiometric) Cleavage:

    • The assembled CX4bX2a\ce{C4b2a} complex functions as an active serine protease rather than a structural building block.
    • A single enzyme complex is not consumed by the reaction; instead, it repeatedly binds and hydrolyzes the highly abundant substrate native C3\text{C3} ([C3]=7.50×10−6  M[\text{C3}] = 7.50 \times 10^{-6}\;\text{M}).
    • Over its functional half-life, one CX4bX2a\ce{C4b2a} complex cleaves upwards of 10310^3 to 10410^4 molecules of C3\text{C3} into soluble anaphylatoxin C3a\text{C3a} and reactive C3b\text{C3b}.
  2. Multilayered Amplification Leading to MAC Assembly:

    • Alternative Loop Amplification: Many newly generated C3b\text{C3b} molecules deposit onto the bacterial surface, where they bind Factor B to form alternative pathway convertases (CX3bBb\ce{C3bBb}), triggering an exponential feedback loop that deposits further C3b\text{C3b}.
    • C5\text{C5} Convertase Formation: C3b\text{C3b} directly associates with existing CX4bX2a\ce{C4b2a} to form the classical C5\text{C5} convertase (CX4bX2aX3b\ce{C4b2a3b}).
    • Terminal Pathway Execution: The CX4bX2aX3b\ce{C4b2a3b} convertase catalytically cleaves hundreds of C5\text{C5} molecules into C5a\text{C5a} and C5b\text{C5b}. Each membrane-bound C5b\text{C5b} nucleates the sequential, non-enzymatic recruitment of C6\text{C6}, C7\text{C7}, C8\text{C8}, and multiple C9\text{C9} monomers (CX5b-9\ce{C5b-9}), producing thousands to millions of lytic membrane attack complexes (MACs) from the initial C1q\text{C1q} activation event.

Typical errors

OverviewACEpath Teacher's Diagnosis

01 The student confuses the classical pathway C3 convertase (C4b2a) with the alternative pathway C3 convertase (C3bBb), leading to an incorrect complex identification.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Classical C3\text{C3} convertase is C3bBb\text{C3bBb}

    Correct

    C4b2a\text{C4b2a} (or C4b2b\text{C4b2b})

    You named C3bBb\text{C3bBb}, which is the C3\text{C3} convertase of the alternative pathway. In the classical (and lectin) pathway, the C3\text{C3} convertase is assembled from C4b\text{C4b} and C2a\text{C2a}, forming C4b2a\text{C4b2a}.

  2. Step 2

    [C4]=2.00×10−6  M  ⟹  [C2]=1.30×10−7  M  ⟹  1.30×10−7  M<2.00×10−6  M  ⟹  C2 is the limiting component[\text{C4}] = 2.00 \times 10^{-6}\;\text{M} \implies [\text{C2}] = 1.30 \times 10^{-7}\;\text{M} \implies 1.30 \times 10^{-7}\;\text{M} < 2.00 \times 10^{-6}\;\text{M} \implies \text{C2 is the limiting component}

  3. Step 3

    The convertase acts as an enzyme with continuous catalytic turnover.   ⟹  \implies One convertase cleaves thousands of C3\text{C3} molecules into C3b\text{C3b}.   ⟹  \implies Deposited C3b\text{C3b} forms C5\text{C5} convertase to cleave C5\text{C5} and drive multiple C5b-9\text{C5b-9} MAC formations.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly identified C2\text{C2} as the stoichiometric limiting factor based on its lower serum concentration.

You accurately articulated that the convertase overcomes stoichiometric limits through catalytic turnover.

You clearly linked the deposition of C3b\text{C3b} to C5\text{C5} convertase formation and downstream MAC assembly.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Convertase Pathway Misidentification

You wrote C3bBb\text{C3bBb} instead of C4b2a\text{C4b2a} for the classical C3\text{C3} convertase.

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You confused the molecular subunits of the classical pathway C3\text{C3} convertase (formed by C4b\text{C4b} and C2a\text{C2a}) with the alternative pathway C3\text{C3} convertase (formed by C3b\text{C3b} and Bb\text{Bb}).

REASONING PATH
Your ACEpath teacher’s suggested approach
Convertase Subunit Origin
  • Classical and lectin pathway convertases derive from C4\text{C4} and C2\text{C2}; alternative pathway convertases derive from C3\text{C3} and Factor B\text{Factor B}.

  • Whenever a question specifies an antibody- or C1\text{C1}-dependent trigger, build the convertase from C4b\text{C4b} and C2a\text{C2a}.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Recall the cleavage products generated by C1s\text{C1s}: C4⟶C4a+C4b\text{C4} \longrightarrow \text{C4a} + \text{C4b} and C2⟶C2b+C2a\text{C2} \longrightarrow \text{C2b} + \text{C2a}.

  2. Combine the membrane-anchored fragment C4b\text{C4b} with the catalytic fragment C2a\text{C2a} to formulate the classical C3\text{C3} convertase: C4b2a\text{C4b2a}.

Final answer

(a) The classical C3\text{C3} convertase is C4b2a\text{C4b2a}; C2\text{C2} is the stoichiometric limiting component. (b) Catalytic turnover of C3\text{C3} by C4b2a\text{C4b2a} amplifies the initial signal, depositing abundant C3b\text{C3b} to assemble C5\text{C5} convertases and terminal C5b-9\text{C5b-9} MACs.

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the distinct multi-protein compositions of the C3\text{C3} and C5\text{C5} convertases across both classical and alternative pathways.

  • Practice writing out the sequential activation cascade from C1q\text{C1q} binding down to membrane attack complex assembly.

OverviewACEpath Teacher's Diagnosis

02 The student mistakes smaller absolute component concentration for overall pathway limitation without comparing C4 directly to C2, erroneously selecting C1q instead of choosing between C4 and C2.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    The classical C3\text{C3} convertase complex is C4b2a\text{C4b2a}.

  2. Step 2

    [C1q]=1.80×10−7  M,  [C2]=1.30×10−7  M,  [C4]=2.00×10−6  M  ⟹  C4 is in excess compared to the other initial components.  ⟹  C4 is the limiting component because it provides the largest fragment[\text{C1q}] = 1.80 \times 10^{-7}\;\text{M},\; [\text{C2}] = 1.30 \times 10^{-7}\;\text{M},\; [\text{C4}] = 2.00 \times 10^{-6}\;\text{M} \implies \text{C4 is in excess compared to the other initial components.} \implies \text{C4 is the limiting component because it provides the largest fragment}

    Correct

    Assembly of C4b2a\text{C4b2a} requires C4b\text{C4b} and C2a\text{C2a} in a 1:11:1 stoichiometric ratio. Since [C2]=1.30×10−7  M<[C4]=2.00×10−6  M[\text{C2}] = 1.30 \times 10^{-7}\;\text{M} < [\text{C4}] = 2.00 \times 10^{-6}\;\text{M}, C2\text{C2} is the theoretical stoichiometric limiting reactant.

    Although you noted that C4\text{C4} is in molar excess, you concluded that C4\text{C4} is the limiting component based on fragment size. In stoichiometric reactions, the limiting reactant is determined solely by molar quantity relative to stoichiometric coefficients, not molecular weight or physical fragment size.

  3. Step 3

    C4b2a is an enzyme that repeatedly cleaves substrate C3 molecules.  ⟹  A single active complex cleaves numerous C3 proteins, amplifying C3b production.  ⟹  Abundant C3b triggers C5 convertase activity and downstream MAC assembly.\text{C4b2a is an enzyme that repeatedly cleaves substrate C3 molecules.} \implies \text{A single active complex cleaves numerous C3 proteins, amplifying C3b production.} \implies \text{Abundant C3b triggers C5 convertase activity and downstream MAC assembly.}

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly identified C4b2a\text{C4b2a} as the active classical pathway C3\text{C3} convertase.

You clearly explained that convertases act as catalytic enzymes rather than stoichiometric reactants, multiplying product output.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Stoichiometric Limiting Reactant Misconception

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You confused molecular or fragment size with chemical stoichiometry, selecting the component that contributes the largest structural piece (C4\text{C4}) rather than the reactant with the lowest molar availability ([C2]<[C4][\text{C2}] < [\text{C4}]).

REASONING PATH
Your ACEpath teacher’s suggested approach
Stoichiometric Limiting Factor in Protein Complex Assembly
  • In a multi-protein complex with 1:11:1 subunit stoichiometry, the component with the lowest molar concentration limits maximum assembly, regardless of subunit mass.

  • Compare the molar concentrations of the assembly subunits; the one with the smaller molar value ([C2]=1.30×10−7  M[\text{C2}] = 1.30 \times 10^{-7}\;\text{M}) is consumed first and thus limits total complex formation.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Identify the stoichiometry of the convertase: 1  molecule of C4b+1  molecule of C2a⟶1  complex of C4b2a1\;\text{molecule of C4b} + 1\;\text{molecule of C2a} \longrightarrow 1\;\text{complex of C4b2a}.

  2. Compare the available molar concentrations: [C2]=1.30×10−7  M[\text{C2}] = 1.30 \times 10^{-7}\;\text{M} and [C4]=2.00×10−6  M[\text{C4}] = 2.00 \times 10^{-6}\;\text{M}.

  3. Identify that [C2]<[C4][\text{C2}] < [\text{C4}] by more than an order of magnitude, meaning C2\text{C2} is depleted first.

Final answer

(a) The classical C3\text{C3} convertase is C4b2a\text{C4b2a}, and C2\text{C2} is the theoretical stoichiometric limiting factor (1.30×10−7  M<2.00×10−6  M1.30 \times 10^{-7}\;\text{M} < 2.00 \times 10^{-6}\;\text{M}). (b) Catalytic enzymatic amplification: C4b2a\text{C4b2a} is an active serine protease that hydrolyzes thousands of C3\text{C3} molecules into C3b\text{C3b}, which forms C5\text{C5} convertase and drives assembly of millions of terminal MACs.

NEXT STEPS
Final Takeaways from Your Teacher
  • Review how limiting reactants apply to macromolecular assembly: molar concentration always determines stoichiometric limits, never subunit mass or fragment volume.

  • Practice identifying 1:11:1 stoichiometric bottlenecks in other biochemical cascades, such as blood coagulation and complement alternative pathways.

OverviewACEpath Teacher's Diagnosis

03 The student treats the C3 cleavage step as a 1:1 stoichiometric consumption reaction rather than enzymatic catalytic amplification, incorrectly concluding that C3 turnover cannot exceed convertase abundance.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    The classical C3\text{C3} convertase complex is CX4bX2a\ce{C4b2a}. [C4]=2.00×10−6  M[\text{C4}] = 2.00 \times 10^{-6}\;\text{M} [C2]=1.30×10−7  M[\text{C2}] = 1.30 \times 10^{-7}\;\text{M} Because 1.30×10−7  M<2.00×10−6  M1.30 \times 10^{-7}\;\text{M} < 2.00 \times 10^{-6}\;\text{M}, C2\text{C2} is the limiting component.

  2. Step 2

    C3\text{C3} convertase binds C3\text{C3} in a fixed stoichiometric complex rather than catalytic turnover. ⟹\Longrightarrow Each CX4bX2a\ce{C4b2a} can only bind and activate one C3\text{C3} molecule before being consumed. ⟹\Longrightarrow Amplification does not occur at C3\text{C3} cleavage, so MACs\text{MACs} are formed only by recruiting extra alternative pathway factors.

    Correct

    CX4bX2a\ce{C4b2a} is an active serine protease enzyme, not a consumed structural component. A single CX4bX2a\ce{C4b2a} complex catalytically cleaves thousands of native C3\text{C3} molecules into C3a\text{C3a} and C3b\text{C3b} over its lifespan, achieving massive catalytic amplification before forming C5\text{C5} convertases and driving terminal MAC\text{MAC} assembly.

    You treated CX4bX2a\ce{C4b2a} as if it were consumed 1:11:1 upon cleaving C3\text{C3}. A convertase is a functional enzyme (serine protease), so one molecule of convertase repeatedly hydrolyzes thousands of soluble C3\text{C3} substrates.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly identified CX4bX2a\ce{C4b2a} as the classical pathway C3\text{C3} convertase.

You correctly evaluated the molar concentrations of C2\text{C2} and C4\text{C4} to conclude that C2\text{C2} is the stoichiometric bottleneck for convertase assembly.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Stoichiometric vs. Catalytic Misconception in Enzyme Cascades

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You confused enzymatic turnover with stoichiometric complex assembly, assuming that convertase complexes are consumed in a 1:11:1 ratio with their substrate rather than acting as multi-turnover catalysts.

REASONING PATH
Your ACEpath teacher’s suggested approach
Identify Enzymatic vs. Structural Components
  • A complement convertase (such as CX4bX2a\ce{C4b2a} or CX3bBb\ce{C3bBb}) is a serine protease enzyme, whereas the terminal membrane attack complex (CX5b-9\ce{C5b-9}) is an assembled stoichiometric pore.

  • Check whether a complement component acts as a catalyst or a consumed reactant before describing pathway amplification.

Calculate Catalytic Amplification
  • Enzymatic amplification factor = molecules of substrate cleavedenzyme complex≫1\frac{\text{molecules of substrate cleaved}}{\text{enzyme complex}} \gg 1.

  • Model the C3\text{C3} cleavage step as repeated enzymatic hydrolysis of abundant substrate by a stable protease, which multiplies active products per trigger event.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Recognize that CX4bX2a\ce{C4b2a} possesses an active serine protease domain on the CX2a\ce{C2a} subunit.

  2. Treat native C3\text{C3} as the abundant soluble substrate (7.50×10−6  M7.50 \times 10^{-6}\;\text{M}) that undergoes continuous catalytic cleavage into C3a\text{C3a} and C3b\text{C3b} by each membrane-bound CX4bX2a\ce{C4b2a}.

  3. State that one CX4bX2a\ce{C4b2a} molecule cleaves 10310^3–10410^4 molecules of C3\text{C3}, creating the primary amplification step that allows a small number of initial convertases to generate millions of downstream MACs\text{MACs}.

Final answer

A single CX4bX2a\ce{C4b2a} complex functions as an active serine protease rather than a consumed reactant, catalytically cleaving thousands of native C3\text{C3} molecules into C3a\text{C3a} and reactive C3b\text{C3b}. This high-turnover catalytic amplification overcomes the low stoichiometric abundance of C2\text{C2}, supplying abundant C3b\text{C3b} to assemble C5\text{C5} convertases (CX4bX2aX3b\ce{C4b2a3b}) and drive the assembly of millions of terminal MACs\text{MACs}.

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the biochemical distinction between stoichiometric assembly (e.g., convertase subunit assembly and MAC\text{MAC} pore formation) and enzymatic cleavage (e.g., C1s\text{C1s}, C3\text{C3} convertase, and C5\text{C5} convertase activity).

  • Practice sketching complement pathway activation with distinct symbols for catalytic complexes versus structural polymers.

Lock it in

Similar question

01

In the lectin complement activation pathway, MASP-2\text{MASP-2} cleaves circulating C4\text{C4} and C2\text{C2}. Identify the resulting C3\text{C3} convertase and determine if its subunit composition differs from the classical pathway C3\text{C3} convertase.

Answer

The lectin pathway C3\text{C3} convertase is C4b2a\text{C4b2a}. It is identical in subunit composition to the classical pathway C3\text{C3} convertase because both pathways utilize C4b\text{C4b} and C2a\text{C2a} as building blocks.

02

A patient has a homozygous loss-of-function mutation in Factor B\text{Factor B}. When serum is incubated with antibody-sensitized sheep erythrocytes, classical pathway-mediated hemolysis proceeds normally. Explain why classical C3\text{C3} convertase assembly and subsequent erythrocyte lysis do not require Factor B\text{Factor B}.

Answer

Classical pathway C3\text{C3} convertase assembly requires only C4b\text{C4b} and C2a\text{C2a} (cleaved by active C1s\text{C1s}). Factor B\text{Factor B} is exclusively required for the alternative pathway convertase (C3bBb\text{C3bBb}), so classical activation and terminal MAC assembly remain fully functional.

03

Suppose a microbial surface stabilizes 5.0×1025.0 \times 10^2 active C4b2a\text{C4b2a} complexes. If each convertase complex exhibits an average catalytic turnover rate of kcat=200  s−1k_{\text{cat}} = 200\;\text{s}^{-1} for C3\text{C3} cleavage and has a functional half-life of 180  s180\;\text{s} before dissociation, calculate the theoretical maximum number of C3\text{C3} molecules cleaved by these complexes during their lifetime.

Answer

Total cleaved C3=(5.0×102 complexes)×(200  s−1)×(180  s)=1.8×107 molecules\text{C3} = (5.0 \times 10^2\text{ complexes}) \times (200\;\text{s}^{-1}) \times (180\;\text{s}) = 1.8 \times 10^7\text{ molecules}. This illustrates how a few hundred stoichiometric convertase complexes catalyze the deposition of tens of millions of C3b\text{C3b} fragments.

Loading workspace…